Skip to main content
CTVA
NYSE Industrial Applications And Services

Corteva Posts $0.08 Q3 Loss, Cuts FY26 EBITDA Outlook to $1.1-1.125B on Brazil Weakness

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Negative
Importance info
8
Price
$10.889
Mkt Cap
$8.101B
52W Low
$9.536
52W High
$14.62
52W Position info
14% above low
Off High info
26% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

CTVA is trading near its 52-week low of $9.536 (14% above the low).

Summary

Corteva reported a $54 million Q3 loss on a 9% sales decline and cut FY26 Adjusted Pro Forma Operating EBITDA guidance to $1.1-$1.125 billion, driven by a 31% organic sales drop in Latin America. The 8-K also furnishes the first New Corteva pro forma financials post-spin and discloses a newly authorized first common dividend.


Key Events · Earnings and Guidance · CTVA

  • Q3 Swings to $54M Loss

    Net sales fell 9% to $1.59 billion, and the pro forma GAAP loss from continuing operations was $54 million, or $0.08 per share, versus $60 million of income a year earlier.

  • Brazil Drives 31% Latin America Organic Decline

    Latin America organic sales dropped 31% on a 24% volume decline as farmers delayed purchases amid liquidity constraints and high interest rates; total company price fell 7%.

  • FY26 EBITDA Guidance Cut to $1.1-1.125B

    Adjusted Pro Forma Operating EBITDA is now guided to $1.1-$1.125 billion and Operating EPS to $0.76-$0.80 per share, reflecting a softer Brazil Crop Protection market than previously anticipated.

  • First Post-Spin Pro Forma Financials Filed

    Exhibit 99.3 gives effect to the October 1 Vylor spin-off, including $2.211 billion of principal debt reduction and a $761 million cash distribution from Vylor; New Corteva carries $944 million of long-term debt and $1.798 billion of cash.


Analysis · CTVA · Industrial Applications And Services

A $54 million loss replaced last year's profit as sales fell 9% to $1.59 billion, and management cut full-year Adjusted Pro Forma Operating EBITDA to $1.1-$1.125 billion from an outlook that had already assumed a flat second half. Brazil accounts for most of the damage: organic sales there fell 31% on a 24% volume drop as farmers delay purchases amid tight liquidity and high interest rates. The filing also delivers the first New Corteva pro forma financials since the October 1 Vylor spin-off, showing a leaner company with $2.211 billion of debt repaid and $761 million of cash received from Vylor, plus a newly authorized first post-spin common dividend. At $10.89 the stock already reflects the miss and the cut, so the incremental news here is the standalone balance sheet and the dividend authorization.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CTVA was trading at $10.89 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $8.1B. The 52-week trading range was $9.54 to $14.62. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTVA - Latest Insights

CTVA
Nov 12, 2026, 5:12 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.26
Real-time Price: $9.25 info
Change: -$0.0100 (-0.11%) info
Market Cap: $6.132B info
CTVA
Nov 12, 2026, 11:47 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $9.82
Real-time Price: $9.25 info
Change: -$0.565 (-6%) info
Market Cap: $6.132B info
CTVA
Nov 12, 2026, 5:45 AM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $10.89
Real-time Price: $9.25 info
Change: -$1.64 (-15%) info
Market Cap: $6.132B info
CTVA
Nov 11, 2026, 4:30 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $12.19
Real-time Price: $9.25 info
Change: -$2.94 (-24%) info
Market Cap: $6.132B info
CTVA
Nov 10, 2026, 5:49 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $12.13
Real-time Price: $9.25 info
Change: -$2.88 (-24%) info
Market Cap: $6.132B info